As Johnson & Johnson (JNJ) Stock Price Declined, Holder Parametric Portfolio Associates LLC Has Raised Position

May 18, 2018 - By Samual Williams

Johnson & Johnson (NYSE:JNJ) LogoInvestors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It is positive, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. 41,823 are owned by Doheny Asset Ca. Cambiar Limited Liability Co, Colorado-based fund reported 296,173 shares. Willingdon Wealth Mgmt stated it has 2.28% of its portfolio in Johnson & Johnson (NYSE:JNJ). Wheatland Advsrs owns 17,878 shares or 2.02% of their US portfolio. Richard Bernstein Advisors Limited invested in 0.6% or 98,314 shares. Hengehold Cap Mngmt Limited holds 17,544 shares or 0.64% of its portfolio. Illinois-based New England Rech Mgmt Inc has invested 3.12% in Johnson & Johnson (NYSE:JNJ). Ballentine Prns Llc accumulated 24,179 shares. Alpha Windward Ltd Liability Co reported 3,152 shares or 0.26% of all its holdings. Dafna Cap Mngmt Lc, California-based fund reported 9,400 shares. Kansas-based First Financial Bank Of Hutchinson has invested 0.29% in Johnson & Johnson (NYSE:JNJ). Hays Advisory Lc has invested 0.14% in Johnson & Johnson (NYSE:JNJ). Nuveen Asset Management Lc holds 0.3% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 331,384 shares. Hills Bancorporation holds 1.74% or 42,394 shares. Regentatlantic Capital Lc invested in 1.89% or 164,943 shares.

Since February 15, 2018, it had 0 buys, and 1 sale for $20.17 million activity.

Parametric Portfolio Associates Llc increased its stake in Johnson & Johnson (JNJ) by 3.6% based on its latest 2017Q4 regulatory filing with the SEC. Parametric Portfolio Associates Llc bought 289,353 shares as the company’s stock declined 9.21% with the market. The institutional investor held 8.32 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.16 billion, up from 8.03 million at the end of the previous reported quarter. Parametric Portfolio Associates Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $332.18B market cap company. The stock decreased 1.20% or $1.5 during the last trading session, reaching $123.85. About 6.47 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since May 18, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Parametric Portfolio Associates Llc, which manages about $100.26 billion US Long portfolio, decreased its stake in Ishares Tr Russell1000val (IWD) by 174,809 shares to 340,877 shares, valued at $42.39 million in 2017Q4, according to the filing. It also reduced its holding in Patterson Uti Energy Inc Com (NASDAQ:PTEN) by 134,739 shares in the quarter, leaving it with 258,993 shares, and cut its stake in Alleghany Corp (NYSE:Y).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson Sells Off After Earnings” on April 22, 2018, also Finance.Yahoo.com with their article: “Johnson & Johnson Stock Looks Attractive on the Big Dip” published on May 10, 2018, Fool.com published: “Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV)” on May 02, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Johnson & Johnson: Waiting On The Wave” published on May 11, 2018 as well as Seekingalpha.com‘s news article titled: “Johnson & Johnson (JNJ) Consumer and Medical Devices Business Review – Brokers Conference Transcript” with publication date: May 17, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 10 analysts covering Johnson & Johnson (NYSE:JNJ), 5 have Buy rating, 1 Sell and 4 Hold. Therefore 50% are positive. Johnson & Johnson had 17 analyst reports since January 2, 2018 according to SRatingsIntel. The rating was downgraded by JP Morgan on Tuesday, January 2 to “Neutral”. Leerink Swann maintained the shares of JNJ in report on Wednesday, April 18 with “Buy” rating. On Tuesday, January 16 the stock rating was maintained by Jefferies with “Buy”. Credit Suisse upgraded the shares of JNJ in report on Thursday, April 12 to “Buy” rating. The rating was maintained by Jefferies on Monday, February 26 with “Buy”. The rating was maintained by Wells Fargo with “Buy” on Tuesday, February 6. The stock of Johnson & Johnson (NYSE:JNJ) has “Neutral” rating given on Tuesday, February 27 by Citigroup. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Wells Fargo on Wednesday, April 18. As per Friday, March 23, the company rating was maintained by Jefferies. The stock has “Equal-Weight” rating by Morgan Stanley on Tuesday, April 10.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: